Chiasma Provides Corporate Update and Previews Expected 2021 Milestones
MYCAPSSA® launch in US continuing to gain traction with physicians, patients, and payers MYCAPSSA® EMA submission for EU marketing approval
Read moreNasdaq:CHMA
Chiasma Provides Corporate Update and Previews Expected 2021 Milestones
MYCAPSSA® launch in US continuing to gain traction with physicians, patients, and payers MYCAPSSA® EMA submission for EU marketing approval
Read moreChiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results
NEEDHAM, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform
Read moreChiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results
NEEDHAM, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform
Read moreChiasma to Participate in the Jefferies Virtual London Healthcare Conference
NEEDHAM, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company utilizing its delivery platform
Read moreChiasma Reports Third Quarter 2020 Results and Provides MYCAPSSA Launch Update
Launched MYCAPSSA® in U.S. earlier than expected and recognized first net product revenues in September Well capitalized to support the
Read moreChiasma Reports Third Quarter 2020 Results and Provides MYCAPSSA Launch Update
Launched MYCAPSSA® in U.S. earlier than expected and recognized first net product revenues in September Well capitalized to support the
Read moreChiasma Reports Third Quarter 2020 Results and Provides MYCAPSSA Launch Update
Launched MYCAPSSA® in U.S. earlier than expected and recognized first net product revenues in September Well capitalized to support the
Read moreChiasma Reports Third Quarter 2020 Results and Provides MYCAPSSA Launch Update
Launched MYCAPSSA® in U.S. earlier than expected and recognized first net product revenues in September Well capitalized to support the
Read moreChiasma Reinforces Commitment to People with Acromegaly and Advocacy Organizations on Acromegaly Awareness Day
NEEDHAM, Mass., Oct. 30, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA) today recognizes Acromegaly Awareness Day, which is observed
Read more